Overall Score

Revenue Growth Potential

Revenue base is still small at $0.25/share, leaving room for scale if execution improves.

High EV/Sales of 18.3x implies the market is pricing in meaningful long-term growth.

Profitability Trajectory

Margins remain deeply negative, with net margin at -428.0% and operating margin at -312.3%.

ROE (-63.5%) and ROIC (-17.3%) remain sharply negative, indicating poor current capital efficiency.

Financial Strength

Liquidity is solid with a current ratio of 3.87 and cash ratio of 3.12.

Leverage is manageable, with debt-to-equity at 1.02 and net debt to EBITDA still modest at -0.39.

Reinvestment Capital Allocation

Capex remains heavy at 51.1% of revenue, while free cash flow is negative.

R&D intensity is elevated at 71.4% of revenue, but current returns on invested capital remain negative.

Valuation

Valuation remains demanding at 18.3x EV/Sales despite negative earnings and free cash flow.

Price-to-free-cash-flow is negative because FCF remains negative, limiting support for the current multiple.

Risk Profile

Negative operating cash flow and a cash conversion cycle of -6.2 days indicate ongoing execution risk.

Interest coverage is deeply negative, reflecting weak earnings power despite current liquidity.